• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1936年至1974年明尼苏达州奥尔姆斯特德县子宫内暴露于孕激素的后代中的先天性畸形。

Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.

作者信息

Resseguie L J, Hick J F, Bruen J A, Noller K L, O'Fallon W M, Kurland L T

出版信息

Fertil Steril. 1985 Apr;43(4):514-9. doi: 10.1016/s0015-0282(16)48490-6.

DOI:10.1016/s0015-0282(16)48490-6
PMID:3987922
Abstract

Comparison of a cohort of 988 offspring exposed in utero to exogenous progestins with a matched cohort of unexposed offspring did not result in detection of an association of congenital anomalies with exposure. The conclusions are based primarily on outcomes of pregnancy with exposure to progesterone and 17 alpha-hydroxyprogesterone caproate, and may not apply to androgenic progestins. Offspring exposed to combinations of progestins and estrogens were excluded from this study and may have a different distribution of anomalies.

摘要

将988名子宫内暴露于外源性孕激素的后代队列与匹配的未暴露后代队列进行比较,未发现先天性异常与暴露之间存在关联。这些结论主要基于暴露于黄体酮和己酸17α-羟孕酮的妊娠结局,可能不适用于雄激素类孕激素。暴露于孕激素和雌激素组合的后代被排除在本研究之外,可能有不同的异常分布。

相似文献

1
Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974.1936年至1974年明尼苏达州奥尔姆斯特德县子宫内暴露于孕激素的后代中的先天性畸形。
Fertil Steril. 1985 Apr;43(4):514-9. doi: 10.1016/s0015-0282(16)48490-6.
2
Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.与安慰剂相比,对子宫内暴露于己酸17α-羟孕酮的儿童进行随访。
Obstet Gynecol. 2007 Oct;110(4):865-72. doi: 10.1097/01.AOG.0000281348.51499.bc.
3
Effect of 17alpha-hydroxyprogesterone caproate on glucose intolerance in pregnancy.己酸17α-羟孕酮对妊娠期糖耐量异常的影响。
Obstet Gynecol. 2009 Jul;114(1):45-49. doi: 10.1097/AOG.0b013e3181a9454b.
4
Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.孕酮与己酸17α-羟孕酮不同:对产科实践的启示。
Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30.
5
Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.己酸17α-羟孕酮与感染风险的关联
Obstet Gynecol. 2015 Jul;126(1):103-8. doi: 10.1097/AOG.0000000000000881.
6
Vaginal Progesterone Is Associated with Intrahepatic Cholestasis of Pregnancy.阴道用黄体酮与妊娠肝内胆汁淤积症有关。
Am J Perinatol. 2023 Aug;40(11):1158-1162. doi: 10.1055/a-2081-2573. Epub 2023 Apr 26.
7
The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment.孕激素和 17α-羟孕酮己酸酯用于预防早产的安全性:基于证据的评估。
Am J Perinatol. 2012 Oct;29(9):665-72. doi: 10.1055/s-0032-1316444. Epub 2012 Jul 6.
8
9
Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
Am J Obstet Gynecol. 1993 Nov;169(5):1292-8. doi: 10.1016/0002-9378(93)90296-u.
10
Transplacental carcinogenesis (adrenocortical carcinoma) associated with hydroxyprogesterone hexanoate.与己酸羟孕酮相关的经胎盘致癌作用(肾上腺皮质癌)
Lancet. 1983 Sep 3;2(8349):580. doi: 10.1016/s0140-6736(83)90616-5.

引用本文的文献

1
In utero exposure to 17α-hydroxyprogesterone caproate and risk of cancer in offspring.子宫内暴露于 17α-羟孕酮己酸酯与后代癌症风险。
Am J Obstet Gynecol. 2022 Jan;226(1):132.e1-132.e14. doi: 10.1016/j.ajog.2021.10.035. Epub 2021 Nov 9.
2
Progesterone for prevention of preterm birth in women with short cervical length: 2-year infant outcomes.孕酮预防短宫颈长度孕妇早产:2 年婴儿结局。
Ultrasound Obstet Gynecol. 2021 Mar;57(3):431-439. doi: 10.1002/uog.23126. Epub 2021 Feb 12.
3
Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
早期普遍使用口服孕激素预防单胎妊娠早产(SINPRO 研究):一项多中心、随机、双盲、安慰剂对照试验方案。
Trials. 2020 Jan 30;21(1):121. doi: 10.1186/s13063-020-4067-z.
4
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
5
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2017 Oct 31;10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2.
6
The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk.阴道微生物群、宫颈长度与阴道孕酮治疗在早产风险中的相互作用。
Microbiome. 2017 Jan 19;5(1):6. doi: 10.1186/s40168-016-0223-9.
7
A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.孕早期有先兆流产的女性使用地屈孕酮的随机双盲对照试验:一项随机对照试验的研究方案
Trials. 2016 Aug 17;17(1):408. doi: 10.1186/s13063-016-1509-8.
8
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.EUROmediCAT信号检测:对选定的先天性异常与药物关联的评估
Br J Clin Pharmacol. 2016 Oct;82(4):1094-109. doi: 10.1111/bcp.12947. Epub 2016 Jul 7.
9
Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.己酸17-羟孕酮预防早产:药理学考量
Semin Perinatol. 2014 Dec;38(8):516-22. doi: 10.1053/j.semperi.2014.08.013. Epub 2014 Sep 23.
10
Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth.己酸羟孕酮注射液降低早产风险的疗效、安全性及患者可接受性的批判性评价
Patient Prefer Adherence. 2013 Jul 11;7:683-91. doi: 10.2147/PPA.S35612. Print 2013.